Literature DB >> 17949476

Defining the structure of membrane-bound human blood coagulation factor Va.

S Stoilova-McPhie1, C D J Parmenter, K Segers, B O Villoutreix, G A F Nicolaes.   

Abstract

BACKGROUND: Blood coagulation factor (F) Va is the essential protein cofactor to the serine protease FXa. Factor Va stimulates the thrombin-to-prothrombin conversion by the prothrombinase complex, by at least five orders of magnitude. Factor Va binds with very high affinity to phosphatidylserine containing phospholipid membranes, which allows the visualization of its membrane-bound state by transmission electron microscopy (EM).
METHODS: In this paper we present an averaged three-dimensional structure of FVa molecules attached to phosphatidylserine containing lipid tubes, as determined by EM and single particle analysis. The low-resolution FVa three-dimensional structure is compared with the available atomic models for FVa.
RESULTS: The experimental data are combined with the most suitable atomic model and a membrane-bound FVaEM model is proposed that best fits the protein density defined by EM. In the FVaEM model, the C1 and C2 membrane-binding domains are juxtaposed onto the membrane surface and the model geometries indicate a deeper insertion of both C domains into the lipid bilayer than has been previously suggested.
CONCLUSION: The present structure is a first step towards a higher-resolution experimental structure of a human FVa molecule in its membrane-bound conformation, allowing the visualization of individual domains within FVa and its association with the membrane.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17949476     DOI: 10.1111/j.1538-7836.2007.02810.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  8 in total

1.  Interaction of prothrombin with a phospholipid surface: evidence for a membrane-induced conformational change.

Authors:  David F Houston; David J Timson
Journal:  Mol Cell Biochem       Date:  2010-11-16       Impact factor: 3.396

2.  Development and Characterization of a Factor V-Deficient CRISPR Cell Model for the Correction of Mutations.

Authors:  Luis Javier Serrano; Mariano Garcia-Arranz; Juan A De Pablo-Moreno; José Carlos Segovia; Rocío Olivera-Salazar; Damián Garcia-Olmo; Antonio Liras
Journal:  Int J Mol Sci       Date:  2022-05-22       Impact factor: 6.208

3.  Domain organization of membrane-bound factor VIII.

Authors:  Svetla Stoilova-McPhie; Gillian C Lynch; Steven Ludtke; B Montgomery Pettitt
Journal:  Biopolymers       Date:  2013-07       Impact factor: 2.505

4.  Membrane Interaction of the Factor VIIIa Discoidin Domains in Atomistic Detail.

Authors:  Jesper J Madsen; Y Zenmei Ohkubo; Günther H Peters; Johan H Faber; Emad Tajkhorshid; Ole H Olsen
Journal:  Biochemistry       Date:  2015-09-30       Impact factor: 3.162

5.  Dimeric Organization of Blood Coagulation Factor VIII bound to Lipid Nanotubes.

Authors:  Daniela Dalm; Jesus G Galaz-Montoya; Jaimy L Miller; Kirill Grushin; Alex Villalobos; Alexey Y Koyfman; Michael F Schmid; Svetla Stoilova-McPhie
Journal:  Sci Rep       Date:  2015-06-17       Impact factor: 4.379

6.  Lack of recombinant factor VIII B-domain induces phospholipid vesicle aggregation: implications for the immunogenicity of factor VIII.

Authors:  K Grushin; J Miller; D Dalm; E T Parker; J F Healey; P Lollar; S Stoilova-McPhie
Journal:  Haemophilia       Date:  2014-04-21       Impact factor: 4.287

Review 7.  The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V.

Authors:  Juan A De Pablo-Moreno; Luis Javier Serrano; Luis Revuelta; María José Sánchez; Antonio Liras
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

Review 8.  Uncovering Membrane-Bound Models of Coagulation Factors by Combined Experimental and Computational Approaches.

Authors:  Y Zenmei Ohkubo; Jesper J Madsen
Journal:  Thromb Haemost       Date:  2021-07-02       Impact factor: 5.249

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.